Comprehensive Financial Planning Inc. PA Buys New Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Comprehensive Financial Planning Inc. PA purchased a new position in Axon Enterprise, Inc. (NASDAQ:AXON) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 252 shares of the biotechnology company’s stock, valued at approximately $150,000.

Other institutional investors have also added to or reduced their stakes in the company. Asset Dedication LLC grew its stake in Axon Enterprise by 11.3% during the fourth quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock valued at $106,000 after acquiring an additional 18 shares in the last quarter. Bleakley Financial Group LLC boosted its holdings in shares of Axon Enterprise by 1.3% during the 4th quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock valued at $908,000 after purchasing an additional 20 shares during the last quarter. Insigneo Advisory Services LLC grew its position in shares of Axon Enterprise by 1.4% during the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock valued at $627,000 after purchasing an additional 22 shares in the last quarter. Menard Financial Group LLC increased its holdings in shares of Axon Enterprise by 0.8% in the third quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock worth $1,204,000 after purchasing an additional 24 shares during the last quarter. Finally, PFG Investments LLC lifted its position in shares of Axon Enterprise by 0.6% in the third quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company’s stock worth $1,547,000 after buying an additional 25 shares in the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $679.24 on Monday. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The stock’s fifty day moving average is $623.43 and its two-hundred day moving average is $496.32. Axon Enterprise, Inc. has a 52 week low of $255.68 and a 52 week high of $698.67. The company has a market capitalization of $51.79 billion, a PE ratio of 175.51, a price-to-earnings-growth ratio of 6.79 and a beta of 1.05.

Analyst Upgrades and Downgrades

AXON has been the subject of several research analyst reports. JMP Securities raised their price target on Axon Enterprise from $610.00 to $725.00 and gave the company a “market outperform” rating in a report on Tuesday, February 4th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. Northland Securities upped their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. Robert W. Baird lifted their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Finally, The Goldman Sachs Group upped their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research report on Monday, January 27th. One analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $542.15.

Insider Transactions at Axon Enterprise

In other news, insider Jeffrey C. Kunins sold 1,035 shares of the stock in a transaction on Monday, December 23rd. The stock was sold at an average price of $624.47, for a total transaction of $646,326.45. Following the transaction, the insider now owns 124,243 shares of the company’s stock, valued at approximately $77,586,026.21. This represents a 0.83 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares of the company’s stock, valued at $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 50,545 shares of company stock worth $30,721,337. Insiders own 6.10% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.